John, B7H3 is a surface protein very prevalent in aggressive PCa.
So far, there is no specific immunotherapy that targets it, but the literature calls it ‘promising’.
From a quick search there is a LOT of interest right now but I couldn’t find any ongoing clinical trials. Hope this helps.
Phil